The Pregnancy Company

Sera Prognostics is a leading women’s health company utilizing proprietary proteomics and bioinformatics platform to discover, develop and commercialize biomarker tests for major pregnancy-related conditions.

Sera’s first commercial product, the PreTRM® Test, is the only broadly validated, commercially available blood-based biomarker test to predict the risk of preterm birth.

In addition, Sera develops a robust pipeline of novel blood-based biomarker tests for a number of additional pregnancy conditions with the aim of significantly improving maternal and neonatal health and dramatically reducing healthcare costs.